Skip to main content
Top
Published in: Health and Quality of Life Outcomes 1/2008

Open Access 01-12-2008 | Research

Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)

Authors: Ülle Krikmann, Pille Taba, Taavi Lai, Toomas Asser

Published in: Health and Quality of Life Outcomes | Issue 1/2008

Login to get access

Abstract

Introduction

Diagnosis and management of Parkinson's disease (PD) rely heavily on evaluation of clinical symptoms and patients' subjective perception of their condition. The purpose of this study was to evaluate the validity, acceptability, and reliability of the Estonian version of the 39-question Parkinson 's disease Questionnaire (PDQ-39).

Methods

Study subjects were approached during their regular clinic follow-up visits. 104 patients consented to the study and 81 completed questionnaires were used for subsequent testing of psychometric characteristics, validity and reliability.

Results

The content validity was assessed through qualitative content analysis during the pilot study. The patients indicated that the questions were relevant to measure the quality of life of people with PD.
The analysis of means showed that the ceiling and floor effects of domain results were within the limits of 15% of Summary Index and of all domains except Stigma, Social Support and Communication where the ceiling effect was 16% to 24% of the responses. Convergent validity was interpreted through correlation between disease severity and PDQ-39 domains. There was a statistically significant difference between the domain scores in patients with mild versus moderate PD in domains of Mobility, ADL, and Communication but not for Stigma, Social Support and Cognition. The reliability was good, Cronbach alpha for all domains and summary index was over 0.8 and item-test correlations between domains and summary index ranged from 0.56 to 0.83.

Conclusion

The psychometric characteristics of an Estonian version of the PDQ-39 were satisfactory. The results of this study were comparable to the results of previous validation studies in other cultural settings in UK, USA, Canada, Spain and Italy.
The Estonian version of the PDQ-39 is an acceptable, valid and reliable instrument for quality of life measurement in PD patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Shrag A, Ben-Shlomo Y, Quinn NP: Cross-sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London. BMJ 2000, 321: 21–22. 10.1136/bmj.321.7252.21CrossRef Shrag A, Ben-Shlomo Y, Quinn NP: Cross-sectional prevalence survey of idiopathic Parkinson's disease and parkinsonism in London. BMJ 2000, 321: 21–22. 10.1136/bmj.321.7252.21CrossRef
2.
go back to reference Marttila RJ, Rinne UK: Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand 1976, 53: 81–102.CrossRefPubMed Marttila RJ, Rinne UK: Epidemiology of Parkinson's disease in Finland. Acta Neurol Scand 1976, 53: 81–102.CrossRefPubMed
3.
go back to reference Taba P, Asser T: Epidemiology of Parkinson's disease. Reviews in Clinical Gerontology 2005, 14: 211–218. 10.1017/S0959259805001541CrossRef Taba P, Asser T: Epidemiology of Parkinson's disease. Reviews in Clinical Gerontology 2005, 14: 211–218. 10.1017/S0959259805001541CrossRef
4.
go back to reference Fahn S, Elton RL: Members of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale. In Recent Developments in Parkinson's Disease. Edited by: Fahn S, Mardsen CD, Calne DB, Lieberman A. Florham Park, Macmillan Health Care Information; 1987:153–163. Fahn S, Elton RL: Members of the UPDRS Development Committee: Unified Parkinson's Disease Rating Scale. In Recent Developments in Parkinson's Disease. Edited by: Fahn S, Mardsen CD, Calne DB, Lieberman A. Florham Park, Macmillan Health Care Information; 1987:153–163.
6.
go back to reference Peto V, Jenkinson C, Fitzpatrick R, Greenhall R: The development and validation of short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995, 4: 241–248. 10.1007/BF02260863CrossRefPubMed Peto V, Jenkinson C, Fitzpatrick R, Greenhall R: The development and validation of short measure of functioning and well being for individuals with Parkinson's disease. Qual Life Res 1995, 4: 241–248. 10.1007/BF02260863CrossRefPubMed
7.
go back to reference Bowling A: Measuring Disease: a review of disease – specific quality of life measurement scales. Philadelphia. Open University Press Buckingham; 1995. Bowling A: Measuring Disease: a review of disease – specific quality of life measurement scales. Philadelphia. Open University Press Buckingham; 1995.
8.
go back to reference Hays RD, Sherbourne CD, Mazel RM: The Rand 36-item health survey 1.0. Health Econ 1993, 2: 217–227. 10.1002/hec.4730020305CrossRefPubMed Hays RD, Sherbourne CD, Mazel RM: The Rand 36-item health survey 1.0. Health Econ 1993, 2: 217–227. 10.1002/hec.4730020305CrossRefPubMed
9.
go back to reference Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N: Self-reported functioning and well-being in patients with Parkinson's disease: a comparison of the short-form health survey (SF-36) and the Parkinson's Disease questionnaire (PDQ-39). Age Ageing 1995, 24: 505–509. 8588541CrossRefPubMed Jenkinson C, Peto V, Fitzpatrick R, Greenhall R, Hyman N: Self-reported functioning and well-being in patients with Parkinson's disease: a comparison of the short-form health survey (SF-36) and the Parkinson's Disease questionnaire (PDQ-39). Age Ageing 1995, 24: 505–509. 8588541CrossRefPubMed
10.
go back to reference Jenkinson Cr, Fitzpatrick R, Norquist J, Findley L, Hughes K: Cross-cultural evaluation of the Parkinson's Disease Questionnaire: tests of data quality, score reliability, response rate, and scaling assumptions in the United States, Canada, Japan, Italy, and Spain. Journal of Clinical Epidemiology 2003, 56: 843–847. 10.1016/S0895-4356(03)00148-3CrossRefPubMed Jenkinson Cr, Fitzpatrick R, Norquist J, Findley L, Hughes K: Cross-cultural evaluation of the Parkinson's Disease Questionnaire: tests of data quality, score reliability, response rate, and scaling assumptions in the United States, Canada, Japan, Italy, and Spain. Journal of Clinical Epidemiology 2003, 56: 843–847. 10.1016/S0895-4356(03)00148-3CrossRefPubMed
11.
go back to reference Katsarou Z, Bostantjopoulou S, Peto V, Alevriadou A, Kiosseoglou G: Quality of Life in Parkinson's Disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39). Qual Life Res 2001, 10: 159–163. 10.1023/A:1016720400862CrossRefPubMed Katsarou Z, Bostantjopoulou S, Peto V, Alevriadou A, Kiosseoglou G: Quality of Life in Parkinson's Disease: Greek translation and validation of the Parkinson's disease questionnaire (PDQ-39). Qual Life Res 2001, 10: 159–163. 10.1023/A:1016720400862CrossRefPubMed
12.
go back to reference Ma H-I, Hwang W-J, Chen-Sea M-J: Reliability and validity testing of a Chinese-translated version of the 39-item Parkinson's Disease questionnaire (PDQ-39). Qual Life Res 2005, 14: 565–569. 10.1007/s11136-004-0687-0CrossRefPubMed Ma H-I, Hwang W-J, Chen-Sea M-J: Reliability and validity testing of a Chinese-translated version of the 39-item Parkinson's Disease questionnaire (PDQ-39). Qual Life Res 2005, 14: 565–569. 10.1007/s11136-004-0687-0CrossRefPubMed
13.
go back to reference Martinez-Martin P, Frades Payo B: Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. J Neurol 1998, 245: S34-S38. 10.1007/PL00007737CrossRefPubMed Martinez-Martin P, Frades Payo B: Quality of life in Parkinson's disease: validation study of the PDQ-39 Spanish version. J Neurol 1998, 245: S34-S38. 10.1007/PL00007737CrossRefPubMed
14.
go back to reference Mathias SD, Fifer SK, Patrick DL: Rapid translation of quality of life measures for international clinical trials: avoiding errors in the minimalist approach. Qual Life Res 1994, 3: 403–412. 10.1007/BF00435392CrossRefPubMed Mathias SD, Fifer SK, Patrick DL: Rapid translation of quality of life measures for international clinical trials: avoiding errors in the minimalist approach. Qual Life Res 1994, 3: 403–412. 10.1007/BF00435392CrossRefPubMed
15.
go back to reference Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P: Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005, 8: 94–104. 10.1111/j.1524-4733.2005.04054.xCrossRefPubMed Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P: Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005, 8: 94–104. 10.1111/j.1524-4733.2005.04054.xCrossRefPubMed
16.
go back to reference Bushnell DM, Martin ML: Quality of life and Parkinson's disease: Translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39). Qual Life Res 1999, 8: 345–350. 10.1023/A:1008979705027CrossRefPubMed Bushnell DM, Martin ML: Quality of life and Parkinson's disease: Translation and validation of the US Parkinson's Disease Questionnaire (PDQ-39). Qual Life Res 1999, 8: 345–350. 10.1023/A:1008979705027CrossRefPubMed
18.
go back to reference Gibb WRG, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988, 51: 745–752.CrossRefPubMed Gibb WRG, Lees AJ: The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988, 51: 745–752.CrossRefPubMed
19.
go back to reference Folstein MF, Folstein SE, McHugh PR: "Mini-mental State" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12: 189–198. 10.1016/0022-3956(75)90026-6CrossRefPubMed Folstein MF, Folstein SE, McHugh PR: "Mini-mental State" A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12: 189–198. 10.1016/0022-3956(75)90026-6CrossRefPubMed
20.
go back to reference Bowling A: Research methods in health: investigating health and health services. 2nd edition. Philadelphia, Open University Press, Guildford and King's Lynn; 2002:147–155. Bowling A: Research methods in health: investigating health and health services. 2nd edition. Philadelphia, Open University Press, Guildford and King's Lynn; 2002:147–155.
21.
go back to reference Scientific Advisory Committee of the Medical Outcomes Trust: Assessing health status and quality of life instruments: attributes and review criteria. Qual Life Res 2002, 11: 193–205. 10.1023/A:1015291021312CrossRef Scientific Advisory Committee of the Medical Outcomes Trust: Assessing health status and quality of life instruments: attributes and review criteria. Qual Life Res 2002, 11: 193–205. 10.1023/A:1015291021312CrossRef
22.
go back to reference Martinez-Martin P, Serrano-Dueòas M, Vaca-Baquero V: Psychometric characteristic of the Parkinson's disease questionnaire (PDQ-39) – Ecuadorian version. Parkinsonism Relat Disord 2005, 11: 297–304. 10.1016/j.parkreldis.2005.02.003CrossRefPubMed Martinez-Martin P, Serrano-Dueòas M, Vaca-Baquero V: Psychometric characteristic of the Parkinson's disease questionnaire (PDQ-39) – Ecuadorian version. Parkinsonism Relat Disord 2005, 11: 297–304. 10.1016/j.parkreldis.2005.02.003CrossRefPubMed
23.
go back to reference Herodes M, Õun A, Haldre S, Kaasik A-E: Epilepsy in Estonia: A quality of life study. Epilepsia 2001, 42(8):1061–1073. 10.1046/j.1528-1157.2001.0420081061.xCrossRefPubMed Herodes M, Õun A, Haldre S, Kaasik A-E: Epilepsy in Estonia: A quality of life study. Epilepsia 2001, 42(8):1061–1073. 10.1046/j.1528-1157.2001.0420081061.xCrossRefPubMed
24.
go back to reference Jenkinson C, Fitzpatrick R, Peto V: Health-related quality of life measurement in patients with Parkinson's disease. Pharmacoeconomics 1999, 15: 157–165. 10.2165/00019053-199915020-00004CrossRefPubMed Jenkinson C, Fitzpatrick R, Peto V: Health-related quality of life measurement in patients with Parkinson's disease. Pharmacoeconomics 1999, 15: 157–165. 10.2165/00019053-199915020-00004CrossRefPubMed
25.
go back to reference Fitzpatrick R, Jenkinson C, Peto V, Hyman N, Greenhall R: Desirable properties for instruments assessing quality of life: evidence from the PDQ-39. J Neurol Neurosurg Psychiatry 1997, 62(1):104.CrossRefPubMed Fitzpatrick R, Jenkinson C, Peto V, Hyman N, Greenhall R: Desirable properties for instruments assessing quality of life: evidence from the PDQ-39. J Neurol Neurosurg Psychiatry 1997, 62(1):104.CrossRefPubMed
26.
go back to reference Cronbach LJ, Meehl PE: Construct validity in psychological tests. Psychol Bull 1955, 52: 281–302. 10.1037/h0040957CrossRefPubMed Cronbach LJ, Meehl PE: Construct validity in psychological tests. Psychol Bull 1955, 52: 281–302. 10.1037/h0040957CrossRefPubMed
27.
go back to reference Taba P, Asser T: Prevalence of Parkinson's disease in Estonia. Acta Neurol Scand 2002, 106: 276–281. 10.1034/j.1600-0404.2002.01286.xCrossRefPubMed Taba P, Asser T: Prevalence of Parkinson's disease in Estonia. Acta Neurol Scand 2002, 106: 276–281. 10.1034/j.1600-0404.2002.01286.xCrossRefPubMed
Metadata
Title
Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)
Authors
Ülle Krikmann
Pille Taba
Taavi Lai
Toomas Asser
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2008
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/1477-7525-6-23

Other articles of this Issue 1/2008

Health and Quality of Life Outcomes 1/2008 Go to the issue